Latest Influenza Vaccine Available now
Flu Subsidy Scheme eligible for Singaporeans & PRs (Pay subsidized rate of $10 for Consultation and Treatment) & Merdeka Generation /Pioneer Generation seniors (Pay subsidized rate of $5) for patients diagnosed with Acute Respiratory Infections (ARIs). Please make your appointment at Tel: 6694 1661.
AIPC is part of MOH's Swab & Go Home programme. Our clinic can carry out the COVID-19 Swab test for anyone who meets the MOH medical criteria. From 1 Jul 20, all individuals aged 13 and above, diagnosed with ARI will be COVID Swab-tested. Cost of Swab test to be borne by Ministry of Health Singapore.
AIPC is part of the National Influenza Sentinel Surveillance programme with MOH. If you have a fever of > 38 degrees with a cough, our clinic is able to test for COVID-19. For children below 12 years old with clinical diagnosis of HFMD (eg fever, oral ulcers, rash), our clinic can test for Hand Foot & Mouth Disease (The tests are for surveillance purposes only).
Up to $400 per Medisave Account per year can be used for Vaccinations under the National Adult Immunisation Schedule - Influenza, Pneumococcal (PCV13/PPSV), Human Papillomavirus (HPV2/HPV4), Hepatitis B, Tetanus, Diphtheria & Pertussis (Tdap), Measles, Mumps & Rubella (MMR) and Chickenpox (Varicella).
Asymptomatic or Presymptomatic ‘Silent’ Transmission
Asymptomatic: people who carry the active virus in their body but never develop any symptoms
Presymptomatic: people who have been infected and are incubating the virus but don't yet show symptoms
Very mildly symptomatic: people who feel a little unwell from a COVID-19 infection but continue to come in close contact with others
The percentage of the population infected with COVID-19 implied by the official case count and the serology survey differs widely (Ref : The Economist – Uncertainty’s Principals, Science & Technology 2 May 20). Samples of mass testing in various cities have shown actual infection rates ranging from 2.5% to 20%.
According to a study by the Center for Infectious Disease Research and Policy, University of Minnesota, many asymptomatic COVID-19 cases are undetected and there are indications that screening symptomatic contacts with a single throat swab test for SARS-CoV-2 might lead to an underestimate of the rate of infection and that asymptomatic persons can repeatedly revert between positive and negative PCR results on throat specimens.
The Centre for Evidence-Based Medicine, University of Oxford found that between 5% and 80% of people testing positive for SARS-CoV-2 may be asymptomatic, presymptomatic or show mild symptoms. Thus symptom-based screening will miss cases, perhaps a lot of them. Their research also found children and young adults can be asymptomatic.
COVID-19 SARS-CoV-2 Virus Information
Infectious Viral Shedding
Another study by the Academy of Medicine, Singapore found that the infectious period of SARS-CoV-2 in symptomatic individuals may begin around 2 days before the onset of symptoms, and persists for about 7-10 days after the onset of symptoms. Viable virus was not found after the second week of illness despite the persistence of PCR detection of RNA (that is a false positive PCR test). Thus viral RNA detection by PCR does not equate to infectiousness or viable virus. A small but important study from Germany found that the degree of viral shedding was very high in the first week of symptoms. Infectious virus was cultured from throat and lung specimens in the first week of symptoms, but none after day 8 in spite of high viral loads detected by regular PCR tests.
Scientists from the University of Texas at Austin in a study to be published in the journal, Emerging Infectious Diseases found that the serial interval (time between one person developing the symptoms of a condition and a second person becoming infected and developing symptoms) for SARS-CoV-2 was approximately 4-5 days. The shorter the serial interval makes an epidemic harder to contain and more likely to spread quickly.
A modelling paper in Science suggests that in China before the lockdown, undiscovered cases — mainly people with "mild, limited or no symptoms" — were less infectious than known cases but were still possibly responsible for 79% of transmission, because so many of them continued to congregate or travel while contagious.
It is estimated by other papers from Singapore and China that people who had not yet developed symptoms transmitted around 6-13% of the cases studied. People can transmit the virus before symptoms begin during the incubation period, and the time between transmission and symptoms could be anything from 2-14 days.
< COVID Toes in otherwise Asymptomatic patients
Some Pre-symptomatic patients have displayed this condition.
COVID-19 Health Statistics
Researchers from China's Center for Disease Control and Prevention in a study of 72,000 COVID-19 patients found a 2.3% death rate.
A total of 81% of cases in a JAMA study were classified as mild, meaning they did not result in pneumonia or resulted in only mild pneumonia. Fourteen percent of cases were severe (marked by difficulty breathing), and 5% were critical (respiratory failure, septic shock, and/or multiple organ dysfunction or failure).
COVID-19 is less deadly but more transmissible than SARS or MERS. So looking on the bright side, based on the statistics, 97.7% of infected COVID-19 cases will survive. Upwards of 70% depending on your health status, will be asymptomatic. The remaining cases might display mild to more serious symptoms if you have any of the risk factors (Use this Prognostic Tool to assess your COVID-19 risk of complications).
Continue to take Safety preventive measures until the COVID-19 vaccine becomes available. This is estimated to be in the second half of 2021, according to GSK & Sanofi, the 2 biggest vaccine makers in the world.
COVID SARS-CoV-2 Life cycle / Viral structure / Immune response
Health Assessment & Screening Packages
Co-infection of COVID-19 with other infectious diseases is possible.
Reduce your risk of getting sick with COVID-19
Vitamins & Nutrients for a Well-functioning Immune Systems to Protect against COVID-19 & other Viral Infections
(Ref: Nutrients. 2020 Apr 23;12(4). pii: E1181. doi: 10.3390/nu12041181 Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections Calder PC1, Carr AC2, Gombart AF3, Eggersdorfer M4.
Healthy Diets for Optimal Health
Groups at Higher Risk for Severe Illness in a COVID-19 Infection
Comorbidities & Underlying Health Conditions in COVID-19 Patients with Complications
· Immunodeficiency / Immunocompromised eg HIV AIDS
· People aged 65 and older
(Ref: https://www.nature.com/articles/s41430-020-0642-3.pdf, Dailymail.co.uk, https://pubmed.ncbi.nlm.nih.gov/32320003/, Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis https://erj.ersjournals.com/content/early/2020/03/17/13993003.00547-2020
Accredited Medical Clinic - Singapore MOH Chronic Disease Management Programme (CDMP)
The information provided in this website is for knowledge purposes only. It does not constitute medical advice.
Should you encounter any medical problem that you are unsure of, always consult your doctor or health care provider for assistance and medical advice.
Dr Don V H LAU Chairperson of AMDA Singapore
MBBS (Monash), B.Med.Sc.(Hons) (Monash), Grad.Dip.Derm.(Wales,UK)
AMDA International Peace Clinic is a part of AMDA (Association of Medical Doctors of Asia). We are part of the network of AMDA Peace Clinics & Friendship Hospitals around the world. We dedicate part of our profits to AMDA's worldwide Emergency Disaster Aid Relief missions, Social Development projects and Vaccination programmes.
AMDA, founded in 1984 has carried out more than 200 medical missions, contributing medical expertise and supplies in 65 countries over the last 36 years. AMDA holds General Consultative Status with the United Nations Economic & Social Council (UN ECOSOC) since 1995.
AMDA International Chapters Afghanistan Albania Bosnia & Herzegovina Bangladesh Bolivia Cambodia Canada Colombia Guyana Haiti Honduras India Indonesia Kazakhstan Korea Kosovo Malaysia Mongolia Nepal New Zealand Pakistan Peru Philippines Sakha Republic Singapore Sri Lanka Sudan Taiwan Uganda Vietnam Zambia
9 Taman Serasi #01-11, Botanic Garden View
Tel : 65-6694-1661 Fax : 65-6694 1771
Email : email@example.com
Monday to Friday: 9am-12.30pm / 2pm-6.30pm Saturday: 9.30am-1pm
*Last registration is 30mins before the closing time
Closed on Sundays & Public Holidays
- Cashless service with most International Insurance companies and Insurance Medical cards are accepted
- Japanese, German, French & Mandarin-speaking Doctors and Medical staff.
Please contact us at Tel: 66941661 to make an appointment.
MBBS (Monash), B Med Sc (Hons) (Monash), Dip Pract Derm (Wales, UK)
Chairperson of AMDA Singapore
MD (Duke-NUS), PhD (Glasgow), M Sc (UK), DLSHTM, B Med Sc (Birmingham)
Doctor of Chiropractic Southern California University of Health Science
The Chiropractic Association Singapore, Japan Chiropractic Register, American Chiropractic Association, California Chiropractic Association
Physiotherapy-trained NBCE The National Board of Chiropractic Examiners
Dr Lee Sao Bing – Opthalmologist (in-house Specialist)
MBBS, MMed(Ophth), FRCSEd(Ophth), MD, FAMS
Dr Pang Yoke Teen – ENT (Visiting Consultant)
FRCS (ORL), FRCS(EDIN), (FRCSGLASG), FAMS, MBBS
Jul 04, 20 12:48 AM
Learn about the symptoms and risks of old age diseases.
Jul 01, 20 09:42 PM
Comprehensive information about common lung problems and pulmonary health issues.
Jun 30, 20 08:34 AM
The Deep Muscle Stimulator (DMS) uses percussion, mechanical vibrations that reach deep into the muscle tissue to stimulate proprioceptive functions.
AMDA International Peace Clinic dedicates part of our profits to AMDA's Worldwide Emergency Disaster Aid Relief missions, Social Development projects & Vaccination programmes.
Founder & President of AMDA - Association of Medical Doctors of Asia
AMDA Emergency Aid Relief Kumamoto Earthquake Apr 16
Email : Admin@AMDA.sg